Martin O’Rourke

905 total citations
25 papers, 612 citations indexed

About

Martin O’Rourke is a scholar working on Molecular Biology, Microbiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Martin O’Rourke has authored 25 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Microbiology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Martin O’Rourke's work include Antimicrobial Peptides and Activities (11 papers), Neurobiology and Insect Physiology Research (7 papers) and Signaling Pathways in Disease (5 papers). Martin O’Rourke is often cited by papers focused on Antimicrobial Peptides and Activities (11 papers), Neurobiology and Insect Physiology Research (7 papers) and Signaling Pathways in Disease (5 papers). Martin O’Rourke collaborates with scholars based in United Kingdom, China and Australia. Martin O’Rourke's co-authors include David G. Hirst, Chris Shaw, Tianbao Chen, Tracy Robson, Pingfan Rao, Stephen McClean, David F. Orr, Anthony J. Bjourson, Andrea Valentine and Helen O. McCarthy and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Martin O’Rourke

25 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin O’Rourke United Kingdom	15	341	168	151	117	108	25	612
Paz Moreno-Murciano Spain	10	471 1.4×	38 0.2×	272 1.8×	85 0.7×	22 0.2×	16	735
Vasily V. Ivanenkov United States	16	636 1.9×	25 0.1×	116 0.8×	115 1.0×	21 0.2×	24	875
Nethaji Thiyagarajan United Kingdom	15	494 1.4×	13 0.1×	80 0.5×	45 0.4×	28 0.3×	25	681
Takashi Morita Japan	11	300 0.9×	16 0.1×	344 2.3×	23 0.2×	47 0.4×	14	539
I V Filippovich Russia	13	219 0.6×	14 0.1×	157 1.0×	79 0.7×	11 0.1×	22	420
Roberta Saldanha-Gama Brazil	12	236 0.7×	18 0.1×	139 0.9×	44 0.4×	11 0.1×	16	438
Elisabeth Gardiner United States	11	501 1.5×	17 0.1×	36 0.2×	96 0.8×	123 1.1×	15	835
Samer Hanna United States	14	513 1.5×	16 0.1×	31 0.2×	104 0.9×	48 0.4×	17	802
Alejandra Loyola Chile	19	1.8k 5.2×	13 0.1×	154 1.0×	103 0.9×	24 0.2×	32	2.0k
Leslie A. Nangle United States	15	1.4k 4.2×	18 0.1×	151 1.0×	46 0.4×	253 2.3×	29	1.7k

Countries citing papers authored by Martin O’Rourke

Since Specialization

Citations

This map shows the geographic impact of Martin O’Rourke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin O’Rourke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin O’Rourke more than expected).

Fields of papers citing papers by Martin O’Rourke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin O’Rourke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin O’Rourke. The network helps show where Martin O’Rourke may publish in the future.

Co-authorship network of co-authors of Martin O’Rourke

This figure shows the co-authorship network connecting the top 25 collaborators of Martin O’Rourke. A scholar is included among the top collaborators of Martin O’Rourke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin O’Rourke. Martin O’Rourke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Page, Natalie, Mark Wappett, C. O'Dowd, et al.. (2022). Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development. Scientific Reports. 12(1). 15715–15715. 8 indexed citations

McClements, Lana, Stephanie Annett, Anita Yakkundi, et al.. (2019). FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4. BMC Cancer. 19(1). 351–351. 49 indexed citations

Roman, Shilina & Martin O’Rourke. (2018). Translational Platform for Immuno-Oncology Discovery. Genetic Engineering & Biotechnology News. 38(16). 10–11. 1 indexed citations

Hartman, Steven J., Tracy Kleinheinz, Jonathan White, et al.. (2017). Abstract 3621: Characterization of the effects of estrogen receptor alpha Y537S and D538G mutations on receptor pharmacology. Cancer Research. 77(13_Supplement). 3621–3621. 1 indexed citations

McCrudden, Cian M., Martin O’Rourke, Declan O’Rourke, et al.. (2015). Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself. PLoS ONE. 10(2). e0118187–e0118187. 14 indexed citations

Higgins, Catherine, Zenobia D’Costa, Martin O’Rourke, et al.. (2014). P3 SAR exploration of biphenyl carbamate based Legumain inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(11). 2521–2524. 9 indexed citations

Valentine, Andrea, Martin O’Rourke, Anita Yakkundi, et al.. (2011). FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism. Clinical Cancer Research. 17(5). 1044–1056. 44 indexed citations

McKeen, Hayley D., Christopher Byrne, Puthen V. Jithesh, et al.. (2010). FKBPL Regulates Estrogen Receptor Signaling and Determines Response to Endocrine Therapy. Cancer Research. 70(3). 1090–1100. 35 indexed citations

Ali, Majid, Brian A. Telfer, Cian M. McCrudden, et al.. (2009). Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo ?. Clinical Cancer Research. 15(19). 6106–6112. 42 indexed citations

10.

Zhou, Jianwu, Anthony J. Bjourson, Tianbao Chen, et al.. (2007). Bradykinin-related peptides, including a novel structural variant, (Val1)-bradykinin, from the skin secretion of Guenther's frog, Hylarana guentheri and their molecular precursors. Peptides. 28(4). 781–789. 15 indexed citations

11.

McCrudden, Cian M., Mei Zhou, Tianbao Chen, et al.. (2007). The complex array of bradykinin-related peptides (BRPs) in the peptidome of pickerel frog (Rana palustris) skin secretion is the product of transcriptional economy. Peptides. 28(6). 1275–1281. 13 indexed citations

12.

Kwok, Hang Fai, et al.. (2007). Helokinestatin: A new bradykinin B2 receptor antagonist decapeptide from lizard venom. Peptides. 29(1). 65–72. 19 indexed citations

13.

Graham, R. L., Ciaren Graham, Stephen McClean, et al.. (2005). Identification and functional analysis of a novel bradykinin inhibitory peptide in the venoms of New World Crotalinae pit vipers. Biochemical and Biophysical Research Communications. 338(3). 1587–1592. 46 indexed citations

14.

O’Rourke, Martin, Tianbao Chen, David G. Hirst, Pingfan Rao, & Chris Shaw. (2004). The smooth muscle pharmacology of maximakinin, a receptor-selective, bradykinin-related nonadecapeptide from the venom of the Chinese toad, Bombina maxima. Regulatory Peptides. 121(1-3). 65–72. 17 indexed citations

15.

Chen, Tianbao, Martin O’Rourke, David F. Orr, et al.. (2003). Kinestatin: a novel bradykinin B2 receptor antagonist peptide from the skin secretion of the Chinese toad, Bombina maxima. Regulatory Peptides. 116(1-3). 147–154. 22 indexed citations

16.

Chen, Tianbao, David F. Orr, Martin O’Rourke, et al.. (2003). Pachymedusa dacnicolor tryptophyllin-1: structural characterization, pharmacological activity and cloning of precursor cDNA. Regulatory Peptides. 117(1). 25–32. 30 indexed citations

17.

Chen, Tianbao, David F. Orr, Anthony J. Bjourson, et al.. (2002). Novel bradykinins and their precursor cDNAs from European yellow‐bellied toad (Bombina variegata) skin. European Journal of Biochemistry. 269(18). 4693–4700. 52 indexed citations

18.

Chen, Tianbao, David F. Orr, Anthony J. Bjourson, et al.. (2002). Bradykinins and their precursor cDNAs from the skin of the fire-bellied toad (Bombina orientalis). Peptides. 23(9). 1547–1555. 39 indexed citations

19.

Ruddock, Mark W., et al.. (2000). The effect of nicotinamide on spontaneous and induced activity in smooth and skeletal muscle. Radiotherapy and Oncology. 56(2). 253–257. 9 indexed citations

20.

Worthington, Jenny, et al.. (2000). Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Therapy. 7(13). 1126–1131. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact